» Articles » PMID: 35208497

Effects of Different Drug Therapies and COVID-19 MRNA Vaccination on Semen Quality in a Man with Ankylosing Spondylitis: A Case Report

Abstract

Ankylosing spondylitis (AS) is a condition that affects 0.1% to 0.5% of the adult population. The aim of this case report was to investigate the possible effects of the drugs taken for treatment of AS as well as mRNA vaccination for COVID-19 on semen quality by performing a highly detailed analysis. Sperm characteristics were examined by light microscopy, DNA fragmentation (DFI) was analysed by flow cytometry and morphology was evaluated by transmission electron microscopy (TEM). Semen analysis under therapy with (1) celecoxib and sulphasalazine showed: concentration 47 million/mL, 53% progressive motility, 7% normal morphology and 9.6% DFI, (2) Golimumab and before mRNA Vaccination showed: concentration 108 million/mL, 82% progressive motility, 1% normal morphology and 7.6% DFI, and (3) Golimumab and after 3 doses of mRNA Vaccination showed: concentration 142 million/mL, 85% progressive motility, 1% normal morphology and 6.8% DFI. TEM revealed head, neck and tail abnormalities, as well as the presence of cells with incomplete spermiogenesis white cells and phagocytes in the sample under therapy with celecoxib and sulphasalazine. Golimumab treatment lead to an increased incidence of elongated heads but in general reduced inflammation as no white cells were evident in TEM. The anti-inflamatory drugs celecoxib and sulphasalazine had no adverse effect on sperm quality as all parameters were within normal limits and the patient achieved under that treatment 2 pregnancies following natural conception that lead to the birth of a healthy boy and girl respectively. Anti-TNFa treatment with Golimumab exerted a negative effect on morphology but not on concentration, motility and DFI. After 3 doses of mRNA Vaccination, sperm concentration increased while motility, morphology and DFI remained similar to the values before vaccination suggesting no negative effect of the mRNA vaccine for COVID-19 on sperm quality.

Citing Articles

The Role of One-Carbon Metabolism and Methyl Donors in Medically Assisted Reproduction: A Narrative Review of the Literature.

Sfakianoudis K, Zikopoulos A, Grigoriadis S, Seretis N, Maziotis E, Anifandis G Int J Mol Sci. 2024; 25(9).

PMID: 38732193 PMC: 11084717. DOI: 10.3390/ijms25094977.


Updates in the pathophysiology of COVID-19 infection in male reproductive and sexual health: a literature review.

Alzahrani M, Alkhani K, Alassaf A, Alorainy J, Binsaleh S, Almannie R Front Endocrinol (Lausanne). 2024; 14:1226858.

PMID: 38468633 PMC: 10925715. DOI: 10.3389/fendo.2023.1226858.


Evaluation of Sperm DNA Fragmentation Using Two Different Methods: TUNEL via Fluorescence Microscopy, and Flow Cytometry.

Chatzimeletiou K, Fleva A, Nikolopoulos T, Markopoulou M, Zervakakou G, Papanikolaou K Medicina (Kaunas). 2023; 59(7).

PMID: 37512124 PMC: 10384605. DOI: 10.3390/medicina59071313.


SARS-CoV-2 and male infertility: from short- to long-term impacts.

Dai P, Qiao F, Chen Y, Chan D, Yim H, Fok K J Endocrinol Invest. 2023; 46(8):1491-1507.

PMID: 36917421 PMC: 10013302. DOI: 10.1007/s40618-023-02055-x.


The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review.

Pourmasumi S, Nazari A, Ahmadi Z, Kouni S, de Gregorio C, Koniari I Vaccines (Basel). 2022; 10(12).

PMID: 36560392 PMC: 9783106. DOI: 10.3390/vaccines10121982.


References
1.
Prisant N, Escalier D, Soufir J, Morillon M, Schoevaert D, Misrahi M . Ultrastructural nuclear defects and increased chromosome aneuploidies in spermatozoa with elongated heads. Hum Reprod. 2007; 22(4):1052-9. DOI: 10.1093/humrep/del481. View

2.
Micu M, Micu R, Surd S, Girlovanu M, Bolboaca S, Ostensen M . TNF-α inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment. Rheumatology (Oxford). 2014; 53(7):1250-5. DOI: 10.1093/rheumatology/keu007. View

3.
Ramonda R, Foresta C, Ortolan A, Bertoldo A, Oliviero F, Lorenzin M . Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patients. Fertil Steril. 2013; 101(2):359-65. DOI: 10.1016/j.fertnstert.2013.10.048. View

4.
Abdulla J, Shi J, Roy B, Zhanwen Z, Liu C . Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis. Eur Spine J. 2020; 29(8):1813-1822. DOI: 10.1007/s00586-020-06466-9. View

5.
Leu J, Adedokun O, Gargano C, Hsia E, Xu Z, Shankar G . Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Rheumatology (Oxford). 2018; 58(3):441-446. DOI: 10.1093/rheumatology/key309. View